Trastuzumab
赫赛汀(Herceptin)
The original HER2 antibody that transformed HER2-positive breast cancer into a treatable disease.
At a glance
China price
Verified pricing is not currently available.
NRDL (national insurance)
In NRDL since the 2017 negotiation; biosimilars also available.
Regulatory status
NMPA approved (2002, 2020); NRDL (2017)
What this meansSupported by a credible secondary source but not yet independently confirmed against a primary source.
SourceNo independent source on file.
NotesApproval status from public regulatory reporting.
What it treats
HER2-positive breast cancer (early and metastatic); HER2-positive gastric cancer.
Sources & verification
No independent source is currently on file. We have not independently verified this information.
Reader discussion
Public comments about Trastuzumab. Discussion is not medical advice, and a comment is not an endorsement or a verified fact. Open the full forum.